PTC Therapeutics | PTCT - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 171.09M 1.9M 2026-03
Alnylam Pharmaceuticals USD 133.73M 290K 2026-06
Amgen USD 541M 1000K 2026-06
BioCryst Pharmaceuticals USD 255.26M 42.2M 2026-06
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.54M 267K 2026-06
Cytokinetics USD 124.43M 2.17M 2026-03
Daiichi Sankyo JPY 1.82B 30.68M 2026-06
Enanta Pharmaceuticals USD 212K 1000 2023-12
Gilead Sciences USD 1.24B 1000K 2026-06
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 165.64M 265K 2026-06
Ironwood Pharmaceuticals USD 160K 0 2024-12
Karyopharm Therapeutics USD 22.54M 4.23M 2026-03
Novartis USD 1.9B 7.38M 2026-06
Pfizer USD 5.7B 0 2026-06
PTC Therapeutics USD 82.88M 1.41M 2026-03
Puma Biotechnology USD 5K 0 2024-06
Roche Holding CHF 796.77M 1.15M 2026-06
Sarepta Therapeutics USD 105.62M 53K 2026-06
TG Therapeutics USD 153.08M 2.23M 2026-06
Ultragenyx Pharmaceutical USD 98.3M 1.7M 2026-03
Vertex Pharmaceuticals USD 253.3M 900K 2026-06
Xencor USD 74.33M 265K 2026-06